Fulgent Genetics, Inc. (FLGT)
15.20
+0.43
(+2.91%)
USD |
NASDAQ |
Mar 16, 10:07
Fulgent Genetics EPS Diluted (Quarterly) : -0.7559 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.052 |
| Quest Diagnostics, Inc. | 2.188 |
| CytoSorbents Corp. | -0.0505 |
| Cardiac Biotech Solutions, Inc. | -0.0035 |
| Odyssey Health, Inc. | -0.0334 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.65M |
| Revenue (Quarterly) | 83.34M |
| Total Expenses (Quarterly) | 106.75M |
| Enterprise Value | 127.96M |
| Gross Profit Margin (Quarterly) | 36.67% |
| Profit Margin (Quarterly) | -28.38% |
| Earnings Yield | -12.93% |
| Normalized Earnings Yield | -11.43 |